| 1. |
- Göök, A., et al.
(författare)
-
Photo-fission at the S-DALINAC
- 2009
-
Ingår i: 4th international workshop on nuclear fission and fission-product spectroscopy. - : American Institute of Physics (AIP). - 9780735407145 ; , s. 351-354
-
Konferensbidrag (övrigt vetenskapligt/konstnärligt)abstract
- Experiments on photo-induced fission of 238U and 234U using bremsstrahlung with endpoint energies between 6 MeV and 9 MeV have been carried out at the superconducting Darmstadt electron linear accelerator S-DALINAC. A twin Frisch grid ionization chamber has been used to determine energy and mass distributions via the 2E-technique. The fission fragment emission angle, which is used to correct for energy loss in the target and backing material for a correct determination of fragment energy and mass, is deduced from the time difference between cathode and anode signals. The research program including the foreseen search for parity violation in photo-induced fission and first experimental results will be presented. © 2009 American Institute of Physics.
|
|
| 2. |
- McMurray, J, et al.
(författare)
-
Practical recommendations for the use of ACE inhibitors, beta-blockers, aldosterone antagonists and angiotensin receptor blockers in heart failure: Putting guidelines into practice
- 2005
-
Ingår i: European Journal of Heart Failure. - : Wiley. - 1879-0844 .- 1388-9842. ; 7:5, s. 710-721
-
Tidskriftsartikel (refereegranskat)abstract
- Surveys of prescribing patterns in both hospitals and primary care have usually shown delays in translating the evidence from clinical trials of pharmacological agents into clinical practice, thereby denying patients with heart failure (HF) the benefits of drug treatments proven to improve well-being and prolong life. This may be due to unfamiliarity with the evidence-base for these therapies, the clinical guidelines recommending the use of these treatments or both, as well as concerns regarding adverse events. ACE inhibitors have long been the cornerstone of therapy for systolic HF irrespective of aetiology. Recent trials have now shown that treatment with beta-blockers, aldosterone antagonists and angiotensin receptor blockers also leads to substantial improvements in outcome. In order to accelerate the safe uptake of these treatments and to ensure that all eligible patients receive the most appropriate medications, a clear and concise set of clinical recommendations has been prepared by a group of clinicians with practical expertise in the management of HE The objective of these recommendations is to provide practical guidance for non-specialists, in order to increase the use of evidenced based therapy for HF. These practical recommendations are meant to serve as a supplement to, rather than replacement of, existing HF guidelines.
|
|
| 3. |
|
|
| 4. |
|
|
